FDA Drug Application (022387) for TYVASO by UNITED THERAP

Back to FDA Applications sponsored by UNITED THERAP

Application Number022387
Product Number001
FormSOLUTION;INHALATION
Dosage0.6MG/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTYVASO
Active IngredientTREPROSTINIL

Active IngredientCount
List of drugs with Active Ingredient TREPROSTINIL3


Back to FDA Applications sponsored by UNITED THERAP